IPC classes for russian patent Hafnia alvei bacteria strain, capable of producing thermolabile lt-enterotoxin. RU patent 2514656. (RU 2514656):
Another patents in same IPC classes:
Biological preparation for leguminous crop of liquid form based on nodule bacteria / 2514217
Biological preparation comprises the culture fluid containing the strain of nitrogen-fixing nodule bacteria with a titre of not less than 107 CFU/ml, and an aqueous solution containing (wt %): sodium carboxymethyl cellulose (2.0-5.0), potassium sorbate (0.5-3.0) and glycerol (1.0-5.0), mixed in a ratio of from 1:1 to 1:2.
|
Method of obtaining androst-4,9(11)-dien-3,17-dione from phytosterol / 2512076
Invention relates to biotechnology. Claimed is method of obtaining androst-4,9(11)-dien-3,17-dione from phytosterol. Microbiological oxidative elimination of side chain at atom C17 with formation of 9α-hydroxyandrost-4-en-3,17-dione is performed. Biomass is separated. 9α-hydroxyandrost-4-en-3,17-dione is extracted from clarified cultural liquid with aprotic organic solvent, selected from aromatic hydrocarbons or organochlorine hydrocarbons. After that, reaction of 9α-hydroxygroup of 9α- hydroxyandrost-4-en-3,17-dione dehydration is carried out in obtained extract. As dehydration agent applied is mineral acid, which contains water and is selected from group, which includes orthophosphoric, pyrophosphoric and chloric acids. Mineral acid is applied in quantity from 1 to 10 mol per 1 mol of 9α- hydroxyandrost-4-en-3,17-dione. In the process of dehydration reaction removal of excessive water is carried out either in presence of effective quantity of pyrophosphoric acid or by azeotropic distillation.
|
Differential diagnostic nutrient medium for identification of yersinia bacterium / 2511436
Invention refers to biotechnology, microbiology, and concerns the recovery and identification of pseudotuberculosis and intestinal yersiniosis agents (Y. Pseudotuberculosis and Y. Enterocolytica). A nutrient medium contains microbiological agar (dry), lactose, glucose, urea, calcium chloride, 1% alcoholic phenol red, 1% alcoholic methylene blue and distilled water in specific proportions.
|
Method of accelerated growth of staphylococcus aureus for diagnostics of infections associated with delivery of health care / 2511031
Growing of Staphylococcus aureus is carried out in a nutrient medium containing yolk-salt agar. At a stage of preparation for analysis the growth stimulators of Staphylococcus aureus are introduced into the nutrient medium in the form of aqueous solutions at concentrations of 10-4-10-6 wt %. The following compounds are used as growth stimulators: tris(2-hydroxyethyl)ammonium 4-chlorophenyl-sulfanylacetate or tris(2-hydroxyethyl)ammonium 2-chlorophenyloxyacetate or tris(2-hydroxyethyl)ammonium 2-methyl-4-chlorophenyloxyacetate or tris(2-hydroxyethyl)ammonium 1-benzylindol-3-yl-sulfanylacetate.
|
Nutrient medium for growing legionella / 2510828
Invention is production of the nutrient medium, which creates optimal conditions for growing legionella, comprising: enzymatic hydrolyzate of pig lung, enzymatic hydrolyzate of chicken egg yolk, potassium monophosphate, trihydrate disubstituted potassium phosphate, L-cysteine hydrochloride, activated carbon, microbiological agar and distilled water at a predetermined ratio of ingredients.
|
Method of obtaining preparation based on vaccine strain of plague microbe / 2510825
Invention relates to field of biotechnology and deals with method of obtaining preparation based on vaccine strain of plague microbe. Claimed invention includes preparing inoculation native culture of plague microbe, concentration of microbe suspension, preparing vaccine suspension and obtaining dry form of preparation, with process of preparing inoculation culture including cultivation of microbes in liquid nutritional medium in flasks for 48 h at temperature 26…28°C and contibuous aeration with not less than 10 l min-1. with passaged stabilised starting culture, obtained as a result of three successive passages through organism of guinea pigs and mixed with glycerol-lactose-polyglucinum liquid in ratio 2:1; for preparation of vaccine suspension used is optimised in component composition protective drying medium, lyophilisation being carried out with observance of the specified regimen.
|
Method of obtaining preparation based on vaccine strain of plague microbe / 2510825
Invention relates to field of biotechnology and deals with method of obtaining preparation based on vaccine strain of plague microbe. Claimed invention includes preparing inoculation native culture of plague microbe, concentration of microbe suspension, preparing vaccine suspension and obtaining dry form of preparation, with process of preparing inoculation culture including cultivation of microbes in liquid nutritional medium in flasks for 48 h at temperature 26…28°C and contibuous aeration with not less than 10 l min-1. with passaged stabilised starting culture, obtained as a result of three successive passages through organism of guinea pigs and mixed with glycerol-lactose-polyglucinum liquid in ratio 2:1; for preparation of vaccine suspension used is optimised in component composition protective drying medium, lyophilisation being carried out with observance of the specified regimen.
|
Method of production of protective antigen and protein of s-layer ea1of asporogenous recombinant strain in anthracis 55 Δtpa-1spo- / 2492241
Method includes cultivation of previously prepared culture of the recombinant strain B. anthracis 55ΔTPA-1Spo-. The cell mass is separated using the filtration module with a membrane having a pore diameter of 0.2 mcm. Protein EA1 is extracted from the washed cell mass using a buffer with 1% sodium dodecyl sulfate, and purified by diafiltration using membrane filters and two-stage ion-exchange chromatography on hydroxyapatite. The protective antigen is isolated from the culture filtrate and purified by successive steps of concentration and diafiltration.
|
Mycoplasma hyopneumoniae avirulent adjuvant live vaccine / 2489164
Presented group of inventions refers to medicine. There are presented a composition containing an immunologically effective amount of the live avirulent strain Mycoplasma hyopneumoniae, and a method of inducing the immune response on Mycoplasma hyopneumoniae, involving the stage of administering the above composition to an animal. What is presented is a method of preventing or relieving an attack of Mycoplasma hyopneumoniae. There are also presented methods of enhancing the immune response on Mycoplasma hyopneumoniae, involving the stages of administering single or double doses of the above composition to the animal.
|
Method for producing brucellous l-antigen / 2486916
Invention refers to veterinary microbiology, immunology, biotechnology, namely to technology of an antigen for diagnosing brucellosis. The method for producing brucellous L-antigen is implemented as follows. The strain Brucella abortus 19 is cultured in the L-form on a solid nutrient medium prepared of meat-peptone liver glucose-glycerol agar (1.3-1.5% agar) with added 10-15% normal horse serum and streptomycin in a dose of 2.5-5.0 Units/ml at 37-38°C for 4-5 days. Then the prepared L-form culture is emulsified by 0.5% phenolised physiological saline; the suspension is inactivated at temperature 85-90°C for 60 minutes, centrifuged at 3000-5000 rpm for 15-20 minutes; the brucella concentration is specified at 50-60 bln microbial cells; the prepared antigen is titred, standartised by specificity and activity. The latter is used for the purpose of an agglutination test in serological diagnosis of brucellosis. The invention enables higher effectiveness and reliability of diagnosing brucellosis by 20-25%.
|
Method for increasing antigen immunogenecity of b. pseudomallei antigens in experimental melioidosis / 2483752
Method comprises immunising the animals with the use of surface melioidosis antigens in the liposomal form, and for the purpose of the additional stimulation of the cell immunity mechanisms, the immunomodulator Bestim is added to cytokines. The stimulant action of the preparations on the immune system is assessed in dynamics of the immune response as shown by the TDTH level and a degree of chemiluminescence response to zymosan of peritoneal macrophages in the immunised mice. The protective properties of the antigens are stated by mortality rates (the percentage of surviving animals and the average life expectancy) after the control infection with the virulent culture of B. pseudomallei. The immunogenic and protective properties of the antigens are substantially increased through the use of the antigen in the liposomal form and the addition of the cell immunity activator Bestim into the immunisation schedule.
|
Method to produce lypopolysaccharide of plague agent / 2483112
Invention may be used for production of antigens, diagnostic and preventive preparations. The method includes preliminary water and salt treatment of bacterial cells with their subsequent lysis by a buffer solution, containing 0.1 M Teis-HCI pH 8.0, 10 mM EDTA, 1% Triton X-100. Destruction with ultrasound is carried out. The untreated extract of LPS is treated with a ferment complex of proteovibrin until the final concentration of 160 mcg/ml and incubated at 37°C, pH 7.8-8.0 for 18 h. Treatment from nucleic acids is carried out by acidification of a sample with an ice acetic acid to pH 3.2-3.4 and their deposition at 5000 g for 30 min.
|
Method for differentiation of strains helicobacter pylori by multilocal vntr-typing / 2482191
Presented invention refers to medical microbiology, particularly to molecular-genetic typing of the strains Helicobacter pylori. What is presented is a method for differentiation of the strains H.pylori by multilocal VNTR-typing with the PCR involving oligonucleotide primers on VNTR-comprising loci of H.pylori - HpA, HpD, HpE and HpF; the strains H.pylori are differentiated by a number of repetitions in the amplified fragments in each VNTR-comprising locus of H.pylori - HpA, HpD, HpE and HpF that enables genetic typing of the studied strains.
|
New bacteria causing diseases of poultry and vaccine produced from them / 2481393
New strain of bacteria Pasteurella trehalosi is proposed, where the specified bacteria are positive in respect to beta-haemolysis, positive in respect to oxidase, positive in respect to catalase, negative in respect to urease, positive in respect to nitrates, negative in respect to indole, MacConkey-positive, positive in respect to glucose, positive in respect to saccharose, positive in respect to mannitol, negative in respect to arabinose, negative in respect to cellobiose, positive in respect to xylose, negative in respect to salicin, negative in respect to ornithine, negative in respect to esculin, negative in respect to alpha-fucosidase, positive in respect to beta-galactosidase. Also the strain of bacteria Mannheimia haemolytica is proposed. These bacteria are deposited under registration numbers ATCC No. PTA-3667, ATCC No. PTA-3668, ATCC No. PTA-3669.
|
Live attenuated mycoplasma bacterium, vaccine containing it and method for identifying such bacterium / 2473682
Mycoplasma bacterium shows expression lower at least by 25% of one or more one protein specified in a group consisting of piruvate dehydrogenase, enolase, 2-desoxyribose-5-phosphataldolase and ribosomal protein L35. The vaccine containing such strain is applicable for animal vaccination against an infection caused by Mycoplasma bacteria. A method for identifying clones of such bacterium involves: placing an initial population of Mycoplasma bacterium into the attenuation environment to produce a potentially attenuated bacterial population; analysis of separate clones of the potentially attenuated bacterial population in relation to low expression of one or more said proteins; and testing the clones identified as having expression lower at least by 25% of one or more proteins in relation to virulence.
|
|
FIELD: chemistry.
SUBSTANCE: invention relates to biotechnology and can be used to produce thermolabile enterotoxin (LT-enterotoxin) and Hafnia alvei anatoxin when producing a vaccine. The strain is deposited in the State Collection of Pathogenic Microorganisms of FBSI Scientific Centre for Evaluation of Medical Products of the Ministry of Public Health and Social Development of Russia under number 294.
EFFECT: strain has high capacity for producing thermolabile LT-enterotoxin.
1 tbl, 2 ex
The present invention relates to biotechnology and may be used for obtaining of thermolabile enterotoxin (LT-enterotoxin) and toxoid Hafnia alvei in the production of vaccines.
The technical result of the invention is a strain of Hafnia alvei №294, isolated from a patient with an intestinal infection in 2011 at the Municipal institution of public health of the city of Ishimbay of the Republic of Bashkortostan, deposited in the State collection of pathogenic microorganisms, St Petersburg Scientific centre of medical products Ministry of health of Russia under number 294, has a high capacity to produce thermolabile LT-enterotoxin.
Strain Hafnia alvei GKM №294 characterized by the following features.
On biochemical properties strain belongs to the family Enterobacteriaceae kind of Hafnia alvei, because when tested on mikrobiologicheskoe test-system version "Vitek 2 Sistems: 04/01" consistent with biochemical properties of this species.
Cultural characteristics.
Grows on conventional dense nutrient media with formation of characteristic isolated colonies yellowish tint. In mesopatamia the broth is uniform clouded with precipitation.
The study of virulence factors showed that the strain is rare with complex the pathological factors that can cause acute toxic pneumonia mice (the death of animals within 3 hours), necrosis of the skin rabbit (3.5 cm in diameter), swelling of the legs of mice (95 mg), a loop of small bowel rabbit 1,2(V/L), has (alpatovsky, enterohemolysin), adhesive (a positive D-minnesotasvetlana and Dr. minnetrista reaction with chicken erythrocytes), antiinterference, the antilysocyme activities that can protestation test to cause the death of infusoria-shoes within 45 seconds.
This strain is the recommended superproducer thermolabile LT-enterotoxin and as a strain with complex pathogenicity factors. The strain can be used in the production of anatoxinum and to obtain antitoxic serum.
The methods for determining the activity LT-enterotoksina.
Subplantar introduction to mice weighing 15-16 g 0.05 ml of centrifugate 20-hour broth culture causes swelling legs over 100 mg. Aksenova E.V., 1980,
Intranasal introduction of 0.05 ml of 20-hour broth culture causes acute toxic pneumonia at white mice-males weighing 15-16 g (death within 4 hours). Voyno-Yasenetsky NICHOLAS, 1957
Intramuscular 300 million microbial cells 20-hour broth culture causes necrosis of the skin rabbit diameter 3 see
In the experience of the loop of small bowel rabbit with the introduction of 80 million M.L. 20-hour broth culture gives a positive result (V/L=L,2).
Thermally treated at 56 degrees C for 45 min of centrifugal 20-hour broth culture causes swelling of the legs of mice up to 30 mg without causing necrosis skin rabbit. Thermally treated at 100 C 20-hour culture is not causing the accumulation of fluid in an isolated loop of small bowel rabbit (V/L=0,3).
Storage conditions of culture after the freeze drying vials or grown at 37 C by 0.3%MPA (pH of 7.2 to 7.4), filled with sterile vaseline oil at a temperature of 4o C.
Medium for reproduction - broth of Hottinger (pH 7,2), massoperenos agar containing 5% of erythrocytes rabbit at a temperature of 37 C for 24 hours.
Genetic features: HLy+, Ent+MS+MR+LT+ALA+, AKA+. Resistant to ampicillin, ampicillin/sulbactam, aporoximately sensitive fluoroquinolone.
Example 1.
0.1 ml of 1 billion suspension daily agar culture in physiological solution sow in sterile broth, Hottinger (5 ml pH 7,2), incubated in thermostat at 37 C for 20 hours, centrifuged at 6000 rpm within 7 minutes. Received the supernatant (centrifugal) in the amount of 0.05 ml injected subplantar in his left rear leg of male mice weighing 15-18, 24 hours animals kill ether and missing limbs on the ankle foot weighed on torsion scales, with centrifugal strain Hafnia alvei №294 given the difference between the left and right legs not less than 100 mg and 20 strains that can produce LT-enterotoxin from 65 to 90 mg Controls - native sterile broth of Hottinger (pH 7,2) and warmed up at 56 degrees From centrifugal 20-hour broth culture 30-35 mg, respectively.
The results are shown in the table.
Example 2.
0.1 ml of 1 billion suspension daily agar culture sow in the broth of Hottinger (pH 7,2), incubated in thermostat at 37 C for 20 hours, and 80 million M.L. suspension in the volume of 1 ml is injected in an isolated segment of the loop of small bowel rabbit. After 16 hours of animals killed by an air embolism and calculate the ratio of the exudate to the length of the segment (V/L). This 20-hour broth culture of strain Hafnia alvei №294 were able to give an accumulation of fluid in a large number and indicator V/L was 1.2. The remaining 20 strains that can produce LT-enterotoxin figure V/L ranged from 0.9 to 1.0. With the introduction of sterile broth of Hottinger and Greta at 100 C 20-hour broth culture, the volume of accumulated fluid to the length of the segment was 0.25 and 0.3 respectively.
Table
Comparative indicators LT-interpretiruya activity Hafnia alvei
Room strain View
Swelling of feet (mg)
Isolated loop of the small intestine (V/L) 6
Hafnia alvei №294 100 1,3 8 -\- 74 0,9 7 -\- 76 0,9 3 -\- 80 1,0 9 -\- 85 1,0 1 -\- 75 0,8 3 -\- 70 0,7 4 -\- 78 0,9 Control 30
0,25-0,3
Note: the table shows the average data of five swellings.
The strain of bacteria Hafnia alvei, with the capacity to produce thermolabile LT-enterotoxin deposited in The state collection of pathogenic microorganisms III-IV groups of pathogenicity, St Petersburg Scientific centre of medical products Ministry of health of Russia under number 294.
|